Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 21% ± 3% | |
astrocyte | 4 studies | 23% ± 6% | |
endothelial cell | 3 studies | 25% ± 8% | |
GABAergic neuron | 3 studies | 42% ± 6% | |
glutamatergic neuron | 3 studies | 54% ± 10% | |
oligodendrocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 33% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1478.96 | 1445 / 1445 | 100% | 13.91 | 183 / 183 |
prostate | 100% | 2069.13 | 245 / 245 | 100% | 14.42 | 502 / 502 |
breast | 100% | 1656.10 | 459 / 459 | 100% | 16.76 | 1115 / 1118 |
bladder | 100% | 1641.38 | 21 / 21 | 100% | 11.55 | 502 / 504 |
uterus | 100% | 1832.96 | 170 / 170 | 100% | 12.54 | 457 / 459 |
intestine | 100% | 1566.20 | 966 / 966 | 99% | 12.99 | 524 / 527 |
lung | 100% | 1355.54 | 576 / 578 | 100% | 11.95 | 1152 / 1155 |
ovary | 100% | 1753.84 | 180 / 180 | 99% | 11.77 | 426 / 430 |
brain | 99% | 2008.85 | 2618 / 2642 | 100% | 14.08 | 704 / 705 |
skin | 100% | 2237.73 | 1809 / 1809 | 99% | 14.58 | 467 / 472 |
thymus | 100% | 1724.66 | 653 / 653 | 99% | 10.20 | 598 / 605 |
stomach | 100% | 1249.04 | 359 / 359 | 98% | 13.15 | 281 / 286 |
pancreas | 100% | 1013.72 | 327 / 328 | 98% | 9.80 | 175 / 178 |
kidney | 100% | 1359.39 | 89 / 89 | 97% | 8.77 | 874 / 901 |
adrenal gland | 100% | 1906.07 | 258 / 258 | 97% | 9.83 | 222 / 230 |
liver | 100% | 979.23 | 226 / 226 | 95% | 7.26 | 384 / 406 |
adipose | 100% | 1465.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.15 | 29 / 29 |
muscle | 100% | 2164.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1693.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.88 | 1 / 1 |
blood vessel | 100% | 1341.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 10.48 | 79 / 80 |
heart | 97% | 994.95 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 954.77 | 726 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0042797 | Biological process | tRNA transcription by RNA polymerase III |
GO_0045087 | Biological process | innate immune response |
GO_0051607 | Biological process | defense response to virus |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005666 | Cellular component | RNA polymerase III complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0001056 | Molecular function | RNA polymerase III activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0071667 | Molecular function | DNA/RNA hybrid binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003899 | Molecular function | DNA-directed 5'-3' RNA polymerase activity |
Gene name | POLR3A |
Protein name | DNA-directed RNA polymerase subunit (EC 2.7.7.6) DNA-directed RNA polymerase (EC 2.7.7.6) DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160) |
Synonyms | |
Description | FUNCTION: Catalytic core component of RNA polymerase III (Pol III), a DNA-dependent RNA polymerase which synthesizes small non-coding RNAs using the four ribonucleoside triphosphates as substrates. Synthesizes 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci . Pol III-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol III is recruited to DNA promoters type I, II or III with the help of general transcription factors and other specific initiation factors. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Transcription termination involves the release of the RNA transcript and polymerase from the DNA . Forms Pol III active center together with the second largest subunit POLR3B/RPC2. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR3A/RPC1 contributing a Mg(2+)-coordinating DxDGD motif, and POLR3B/RPC2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate . Pol III plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as a nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF-kappa-B through the RIG-I pathway. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. . |
Accessions | A0A8V8TNL6 A0A8V8TNX3 ENST00000473588.2 ENST00000372371.8 A0A8V8TM36 ENST00000698732.1 ENST00000698734.1 ENST00000698731.1 Q7Z755 R4GMX2 A0A8V8TM70 O14802 ENST00000698733.1 |